BioVie Inc.

BIVI | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.43

+$0.05 (+3.62%)

At close: Oct 30, 2026, 4:00 PM ET

$1.43

$0.00 (0.00%)

After-hours: Oct 30, 2026, 4:10 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.62%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

32.8

+2.6 pts

Fundamentals Weak

Market Sentiment Bullish

Moat None

Sector Rank #716/1028 (Top 70%)

Full Analysis

Key Statistics

Market Data

Market Cap $12.42M

1D Range

1.38 1.47

52W Range

0.96 2.28

Valuation (TTM)

PE -0.45

PB 1.21

EV/EBITDA -0.17

Valuation (NTM)

Forward PE 0.02

Forward PEG 0.01

Price Target $0.00

Cash Flow

FCF Yield -153.2%

SBC Adj. FCF Yield -174.5%

SBC Impact -13.9%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 88.0% | 47.6%

FCF 3Y | 5Y 20.3% | 8.4%

Returns

ROA -154.9%

ROE -126.0%

ROIC -214.8%

Financial Health

Net Cash

$8.98M

Current Ratio 3.59

Interest Coverage -1,265.39

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

BioVie Inc. is a clinical-stage biotechnology firm primarily dedicated to the discovery, development, and commercialization of innovative drug treatments across the United States. The company's develo...

Sector Healthcare

Industry Biotechnology

Employees 13

IPO Date Sep 18, 2020

Website bioviepharma.com

Fiscal Year July - June

Full Company Profile

Latest News

No news articles available yet.